These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 4056908

  • 1. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E, Black PM, Liszczak TM, Zervas NT.
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [Abstract] [Full Text] [Related]

  • 2. The effect of very early cisternal irrigation on basilar artery spasm after SAH in the rat model.
    Aydin IH, Onder A.
    Acta Neurochir (Wien); 1991 Dec; 113(1-2):69-73. PubMed ID: 1799145
    [Abstract] [Full Text] [Related]

  • 3. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y, Weir BK, Nosko M, Mosewich R, Tsuji T, Grace M.
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [Abstract] [Full Text] [Related]

  • 4. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
    Nosko M, Weir BK, Lunt A, Grace M, Allen P, Mielke B.
    J Neurosurg; 1987 Mar; 66(3):416-22. PubMed ID: 3819837
    [Abstract] [Full Text] [Related]

  • 5. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM.
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [Abstract] [Full Text] [Related]

  • 6. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T, Mori K, Esaki T, Nakao Y, Tokugawa J, Watanabe M.
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [Abstract] [Full Text] [Related]

  • 7. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
    Hara H, Nosko M, Weir B.
    J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
    Pluta RM, Deka-Starosta A, Zauner A, Morgan JK, Muraszko KM, Oldfield EH.
    J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
    [Abstract] [Full Text] [Related]

  • 9. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y, Hayashi M, Takeuchi H, Kobayashi H, Kawano H, Kabuto M.
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [Abstract] [Full Text] [Related]

  • 10. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.
    Stoodley M, Weihl CC, Zhang ZD, Lin G, Johns LM, Kowalczuk A, Ghadge G, Roos RP, Macdonald RL.
    Neurosurgery; 2000 May; 46(5):1193-202; discussion 1202-3. PubMed ID: 10807252
    [Abstract] [Full Text] [Related]

  • 11. Effect of clot removal on cerebral vasospasm.
    Inagawa T, Yamamoto M, Kamiya K.
    J Neurosurg; 1990 Feb; 72(2):224-30. PubMed ID: 2295920
    [Abstract] [Full Text] [Related]

  • 12. Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm.
    Seifert V, Stolke D, Kunz U, Resch K.
    Neurosurgery; 1988 Sep; 23(3):313-21. PubMed ID: 3147407
    [Abstract] [Full Text] [Related]

  • 13. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T, Wakai S, Asano T, Takakura K, Sano K.
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [Abstract] [Full Text] [Related]

  • 14. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
    Wolf EW, Banerjee A, Soble-Smith J, Dohan FC, White RP, Robertson JT.
    J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
    [Abstract] [Full Text] [Related]

  • 15. Is vasospasm related to proliferative arteriopathy?
    Pluta RM, Zauner A, Morgan JK, Muraszko KM, Oldfield EH.
    J Neurosurg; 1992 Nov; 77(5):740-8. PubMed ID: 1403117
    [Abstract] [Full Text] [Related]

  • 16. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.
    Mori K, Yamamoto T, Miyazaki M, Hara Y, Aiko Y, Koike N, Sakamoto S, Nakao Y, Esaki T.
    J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257
    [Abstract] [Full Text] [Related]

  • 17. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial.
    Hänggi D, Liersch J, Turowski B, Yong M, Steiger HJ.
    J Neurosurg; 2008 Jun; 108(6):1192-9. PubMed ID: 18518727
    [Abstract] [Full Text] [Related]

  • 18. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
    Macdonald RL, Bassiouny M, Johns L, Sajdak M, Marton LS, Weir BK, Hall ED, Andrus PK.
    Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
    [Abstract] [Full Text] [Related]

  • 19. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
    Findlay JM, Weir BK, Steinke D, Tanabe T, Gordon P, Grace M.
    J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
    [Abstract] [Full Text] [Related]

  • 20. Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage.
    Yamaguchi M, Zhou C, Heistad DD, Watanabe Y, Zhang JH.
    Stroke; 2004 Nov; 35(11):2512-7. PubMed ID: 15472087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.